Clinical Trial Update: Haploidentical Stem Cell Transplantation and NK Cell Therapy in Patients With High-risk Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating haploidentical stem cell transplantation with NK cell therapy in high-risk solid tumors, including neuroblastoma and Ewing sar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma
• Neuroblastoma
• Osteosarcoma
• Rhabdomyosarcoma
• Soft Tissue Sarcoma

Drugs mentioned

• haploidentical stem cell transplantation with NK cell therapy

Snippet

Sponsor: Samsung Medical Center | Conditions: Neuroblastoma, Ewing Sarcoma | Phase 2 | Status: UNKNOWN